What one share of Nuo Therapeutics holds
Nuo Therapeutics, Inc. is a Delaware corporation organized in 1998 under the name Informatix Holdings, Inc. In 1999, Autologous Wound Therapy, Inc., an Arkansas Corporation, merged with and into Informatix Holdings, Inc. and the name of the surviving corporation was changed to Autologous Wound Therapy, Inc.
Nuo Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.11 |
|---|---|
| Profit | −$0.04 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.05 |
| Cash and investments | $0.01 |
| Book value | −$0.03 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.05 | −$1.02 | — | — | — | $0.02 |
| 2018 | $0.06 | −$0.07 | — | — | — | −$0.00 |
| 2019 | $0.01 | −$0.05 | $0.00 | −$0.04 | — | −$0.05 |
| 2020 | $0.00 | $0.27 | $0.00 | −$0.00 | — | −$0.02 |
| 2021 | $0.00 | −$0.03 | $0.00 | −$0.00 | — | $0.02 |
| 2022 | $0.00 | −$0.08 | $0.00 | −$0.09 | — | $0.05 |
| 2023 | $0.01 | −$0.08 | $0.00 | −$0.08 | — | $0.02 |
| 2024 | $0.03 | −$0.05 | $0.00 | −$0.05 | — | $0.01 |
| 2025 | $0.07 | −$0.05 | $0.01 | −$0.02 | — | −$0.02 |
Common questions about Nuo Therapeutics
How much does one share of Nuo Therapeutics earn?
Over the last 12 months, Nuo Therapeutics lost $0.04 for each share on $0.11 of sales.
Does Nuo Therapeutics pay a dividend?
Nuo Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Nuo Therapeutics’s book value per share?
Nuo Therapeutics’s book value is negative (−$0.03 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Nuo Therapeutics have?
Each share of Nuo Therapeutics has $0.01 of cash and investments, as of June 30, 2026.
What is Nuo Therapeutics’s free cash flow per share?
−$0.05 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Nuo Therapeutics bought back shares?
Nuo Therapeutics’s share count rose about 223% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.